TheProfitWatch

MYNZ - Mainz Biomed N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.54 -0.11 (-7.14%) --- --- --- -0.11 (-7.14%) -0.06 (-3.9%) 0.0 (0.0%) -0.05 (-3.38%)

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Category: /stock/categories/na
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
7.69
VWAP:
1.43
RVol:
0.0111

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.42 -0.06 (-4.05%) Oct 16 07:34
10m Price decrease 10m 1.42 -0.08 (-5.33%) Oct 16 07:34
60m Price decrease 60m 1.42 -0.08 (-5.33%) Oct 16 07:34

Related News